" class="no-js "lang="en-US"> X-VAX Technology - Pharmtech Focus
Tuesday, January 31, 2023
X-VAX Technology | Pharmtech Focus

X-VAX Technology

About X-VAX Technology

X-VAX Technology

We’re a biotech company committed to developing vaccines against pathogens acquired by mucosal infection such as herpes. Our research leads us to believe that the new approach we’re taking could succeed in defeating herpes by inducing antibodies that mediate the killing of infected cells. We’re strongly committed to this fight, and so far our work has been supported with unprecedented data in multiple preclinical models.

Related Story

X-Vax Technology Appoints Varsha K. Jain, MD as Chief Clinical Development Officer

July 22 2021

X-Vax Technology, Inc. (X-VAX®), a biotechnology company developing vaccines based on a new approach that […]